{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:15:32Z","timestamp":1761156932200,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Project of Medical Innovations Topic in Fujian Province","award":["2019-CXB-34","2019-CXB-34"],"award-info":[{"award-number":["2019-CXB-34","2019-CXB-34"]}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"crossref","award":["3502Z20174023"],"award-info":[{"award-number":["3502Z20174023"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project of Xiamen Scientific and Technological Plan","award":["3502Z20174023"],"award-info":[{"award-number":["3502Z20174023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Liver fibrosis or cirrhosis is associated with the dismal prognosis of hepatocellular carcinoma (HCC), and it might also be involved in intrahepatic cholangiocarcinoma (ICC). The effect of hepatic fibrosis on the survival of ICC patients is still unclear. This study aims to explore whether liver fibrosis impacts the overall survival (OS) and disease-specific survival (DSS) of ICC patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Data of 729 eligible ICC patients receiving different therapies from the Surveillance, Epidemiology, and End Results database (2004\u20132015) were analyzed. Unmatched, propensity score-matched, and propensity score-weighted cohorts were used to investigate the relationships of different fibrosis scores (low fibrosis score vs. high fibrosis score) and survival. A Cox regression and Kaplan\u2013Meier curves were used to explore the influence of fibrosis score on patients\u2019 survival. Stratified analyses based on treatment modality were conducted to compare the survival difference in ICC patients with different fibrosis scores.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Before matching, the one-, three-, and five-year OS were 50.9, 28.0, and 16.1% in the low fibrosis score group (<jats:italic>n<\/jats:italic>\u2009=\u2009465) and 39.3, 20.1, and 8.0% in the high fibrosis score group (<jats:italic>n<\/jats:italic>\u2009=\u2009264) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), respectively. After propensity score matching, the one-, three-, and five-year OS were 45.0, 26.0, and 10.2% in the low fibrosis score group and 36.0, 8.1, and 2.3% in the high fibrosis score group (<jats:italic>P<\/jats:italic>\u2009=\u20090.008), respectively. The multivariate Cox regression results showed that a high fibrosis score was an independent risk factor of OS. Additionally, patients with high fibrosis scores achieved low DSS after matching (<jats:italic>P<\/jats:italic>\u2009=\u20090.032). The survival benefits of the low fibrosis score group were consistent across treatment cohorts.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>High fibrosis scores were associated with poor clinical outcomes of ICC patients receiving different common therapies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-07051-5","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T12:02:55Z","timestamp":1592222575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Jian Xi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peipei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huogui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhezhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijia","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zirong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"issue":"3","key":"7051_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/cam4.1341","volume":"7","author":"M Wang","year":"2018","unstructured":"Wang M, Gao Y, Feng H, Warner E, An M, Jia J, Chen S, Fang M, Ji J, Gu X, et al. A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Cancer Med. 2018;7(3):646\u201354.","journal-title":"Cancer Med"},{"issue":"3","key":"7051_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jhbp.30","volume":"21","author":"T Adachi","year":"2014","unstructured":"Adachi T, Eguchi S. Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to date. J Hepatobiliary Pancreat Sci. 2014;21(3):162\u20138.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"2","key":"7051_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21037\/hbsn.2017.01.06","volume":"6","author":"K Wang","year":"2017","unstructured":"Wang K, Zhang H, Xia Y, Liu J, Shen F. Surgical options for intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6(2):79\u201390.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"5","key":"7051_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/17474124.2017.1309290","volume":"11","author":"AA Rahnemai-Azar","year":"2017","unstructured":"Rahnemai-Azar AA, Weisbrod AB, Dillhoff M, Schmidt C, Pawlik TM. Intrahepatic cholangiocarcinoma: current management and emerging therapies. Expert Rev Gastroenterol Hepatol. 2017;11(5):439\u201349.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"7051_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jso.25305","volume":"119","author":"LS Hu","year":"2019","unstructured":"Hu LS, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, et al. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2019;119(1):21\u20139.","journal-title":"J Surg Oncol"},{"issue":"9935","key":"7051_CR6","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168\u201379.","journal-title":"Lancet"},{"issue":"1","key":"7051_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"7051_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","volume":"7","author":"SL Friedman","year":"2010","unstructured":"Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010;7(8):425\u201336.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"7051_CR9","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","volume":"365","author":"HB El-Serag","year":"2011","unstructured":"El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118\u201327.","journal-title":"N Engl J Med"},{"key":"7051_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","volume":"12","author":"S Affo","year":"2017","unstructured":"Affo S, Yu LX, Schwabe RF. The role of Cancer-associated fibroblasts and fibrosis in liver Cancer. Annu Rev Pathol. 2017;12:153\u201386.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"7051_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0169-2607(03)00069-5","volume":"74","author":"S Rosthoj","year":"2004","unstructured":"Rosthoj S, Andersen PK, Abildstrom SZ. SAS macros for estimation of the cumulative incidence functions based on a cox regression model for competing risks survival data. Comput Methods Prog Biomed. 2004;74(1):69\u201375.","journal-title":"Comput Methods Prog Biomed"},{"issue":"3","key":"7051_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivariate Behav Res"},{"issue":"28","key":"7051_CR13","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379.","journal-title":"Stat Med"},{"issue":"2","key":"7051_CR14","first-page":"215","volume":"9","author":"L Liang","year":"2013","unstructured":"Liang L, Tom G. A weighting analogue to pair matching in propensity score analysis. Int J Biostat. 2013;9(2):215\u201334.","journal-title":"Int J Biostat"},{"issue":"1","key":"7051_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrgastro.2011.222","volume":"9","author":"AE Sirica","year":"2011","unstructured":"Sirica AE. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;9(1):44\u201354.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"7051_CR16","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1002\/hep.26762","volume":"59","author":"AE Sirica","year":"2014","unstructured":"Sirica AE, Gores GJ. Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting. Hepatology. 2014;59(6):2397\u2013402.","journal-title":"Hepatology"},{"issue":"6","key":"7051_CR17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.asjsur.2018.01.001","volume":"41","author":"SK Kamarajah","year":"2018","unstructured":"Kamarajah SK. Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): a surveillance, end results and epidemiology (SEER) database analysis. Asian J Surg. 2018;41(6):551\u201361.","journal-title":"Asian J Surg"},{"issue":"1","key":"7051_CR18","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1186\/s12885-018-4996-z","volume":"18","author":"H Liu","year":"2018","unstructured":"Liu H, Cen D, Yu Y, Wang Y, Liang X, Lin H, Cai X. Does fibrosis have an impact on survival of patients with hepatocellular carcinoma: evidence from the SEER database? BMC Cancer. 2018;18(1):1125.","journal-title":"BMC Cancer"},{"issue":"136","key":"7051_CR19","first-page":"2295","volume":"61","author":"CJ Ko","year":"2014","unstructured":"Ko CJ, Lin PY, Lin KH, Lin CC, Chen YL. Presence of fibrosis is predictive of postoperative survival in patients with small hepatocellular carcinoma. Hepatogastroenterology. 2014;61(136):2295\u2013300.","journal-title":"Hepatogastroenterology"},{"issue":"4","key":"7051_CR20","first-page":"957","volume":"21","author":"C Chuaysri","year":"2009","unstructured":"Chuaysri C, Thuwajit P, Paupairoj A, Chau-In S, Suthiphongchai T, Thuwajit C. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Oncol Rep. 2009;21(4):957\u201369.","journal-title":"Oncol Rep"},{"issue":"9","key":"7051_CR21","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1245\/s10434-009-0568-4","volume":"16","author":"H Okabe","year":"2009","unstructured":"Okabe H, Beppu T, Hayashi H, Horino K, Masuda T, Komori H, Ishikawa S, Watanabe M, Takamori H, Iyama K, et al. Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16(9):2555\u201364.","journal-title":"Ann Surg Oncol"},{"key":"7051_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-4598-9-13","volume":"9","author":"K Utispan","year":"2010","unstructured":"Utispan K, Thuwajit P, Abiko Y, Charngkaew K, Paupairoj A, Chau-in S, Thuwajit C. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Mol Cancer. 2010;9:13.","journal-title":"Mol Cancer"},{"issue":"6","key":"7051_CR23","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/hep.26585","volume":"58","author":"A Claperon","year":"2013","unstructured":"Claperon A, Mergey M, Aoudjehane L, Ho-Bouldoires TH, Wendum D, Prignon A, Merabtene F, Firrincieli D, Desbois-Mouthon C, Scatton O, et al. Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor. Hepatology. 2013;58(6):2001\u201311.","journal-title":"Hepatology"},{"issue":"6","key":"7051_CR24","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/hep.24588","volume":"54","author":"CD Fingas","year":"2011","unstructured":"Fingas CD, Bronk SF, Werneburg NW, Mott JL, Guicciardi ME, Cazanave SC, Mertens JC, Sirica AE, Gores GJ. Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells. Hepatology. 2011;54(6):2076\u201388.","journal-title":"Hepatology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07051-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07051-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07051-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T23:20:22Z","timestamp":1623712822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07051-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7051"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07051-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"30 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. As the SEER dataset is open-access, therefore, the ethical approval by an ethics committee is not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"556"}}